Basal Cell Carcinoma Drug Encourages Both Cancer Regression and Loss of Taste in Patients
American Physiological Society (APS)Researchers at the University of Michigan have identified the pathway responsible for taste changes among users of chemotherapy drugs that treat basal cell carcinoma. Manuscript was chosen as an APSselect article for March.